Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Shanghai Pharmaceuticals Holding Co Ltd
Total Equity
Shanghai Pharmaceuticals Holding Co Ltd
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Total Equity
¥68.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Total Equity
¥69.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Total Equity
¥24B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
13%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Total Equity
¥15.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
22%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Total Equity
¥21B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
22%
|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Total Equity
¥17.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
15%
|
See Also
What is Shanghai Pharmaceuticals Holding Co Ltd's Total Equity?
Total Equity
68.5B
CNY
Based on the financial report for Mar 31, 2024, Shanghai Pharmaceuticals Holding Co Ltd's Total Equity amounts to 68.5B CNY.
What is Shanghai Pharmaceuticals Holding Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
10%
Over the last year, the Total Equity growth was 0%. The average annual Total Equity growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been 13% over the past three years , 11% over the past five years , and 10% over the past ten years .